NuCana plc (NCNA) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
NCNA Profit Margin, ROE & Profitability Analysis
NCNA vs Healthcare Sector: How NuCana plc Compares
How NuCana plc compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is NuCana plc Stock Overvalued? NCNA Valuation Analysis 2026
Based on fundamental analysis, NuCana plc has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
NuCana plc Balance Sheet: NCNA Debt, Cash & Liquidity
NCNA Revenue Growth, EPS Growth & YoY Performance
NCNA SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for NuCana plc (CIK: 0001709626)
📋 Recent SEC Filings
❓ Frequently Asked Questions about NCNA
What is the AI rating for NCNA?
NuCana plc (NCNA) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.
What are NCNA's key strengths?
Claude: Analysis in progress.
What are the risks of investing in NCNA?
Claude: Analysis in progress.
What is NCNA's revenue and growth?
NuCana plc reported revenue of N/A.
Does NCNA pay dividends?
NuCana plc does not currently pay dividends.
Where can I find NCNA SEC filings?
Official SEC filings for NuCana plc (CIK: 0001709626) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is NCNA's EPS?
NuCana plc has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is NCNA's fundamental grade?
Based on our AI fundamental analysis in July 2026, NuCana plc has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is NCNA stock overvalued or undervalued?
Valuation metrics for NCNA: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is NCNA's AI grade for 2026?
Our dual AI analysis gives NuCana plc a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is NCNA's free cash flow?
NuCana plc's operating cash flow is N/A, with capital expenditures of N/A.
How does NCNA compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).